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G and H, Expression of

Model of cell transfer and re-isolation.
A, Model and FACS plots of re-isolated ex-vivo
Rab27-DKO T cells (Treg and Th cells) are similar to WT T cells (Treg and Th cells).
A, Treg (CD4 + CD25 + ) and naïve T cells were FACS purified from WT,
Cd4
Cre Dicer fl/fl R26 eyfp+ and Rab27-DKO mice.
B, Expression of Treg -associated genes determined by qRT-PCR and expressed relative to naïve CD4 + CD25 -T cells. shown. * denotes P<0.05. Tables   Table S1, staining, cells were stimulated with PMA (5ng/ml) and Ionomycin (500ng/ml) for 3 hours with Brefeldin A (5µg/ml) added after 1 hour. Cells were subsequently fixed and permeabilised with BD Cytofix/cytoperm kit (BD). In some assays, primary FACS-purified Treg cells were treated with IL-2 (high dose-500ng/ml), IL2complex (lL-2, 5ng/ml in complex with anti-IL-2, JES6-1A2, 50µg/ml), all-trans retinoic acid (AT-RA,10nM), amphiregulin (AREG, 100ng/ml), Monensin (10µM), GW4869 (10µM) or under hypoxic conditions (1% O 2 ) in a hypoxia workstation chamber (Ruskin Invivo 2 400, Ruskin).
C, Expression of top 40 genes in WT and
Supplementary
AlamarBlue (Invitrogen) was used to monitor cellular density / proliferation inferred from the metabolic activity, according to manufacturers guidelines.
For Cox-2 inhibition, Celecoxib or DMSO, was added to T H 1-polarising cultures on day 0. IFNγ and cellular proliferation was determined on day 3.
Microarray analysis. For microarray analysis, cDNA was generated from total RNA and quality was determined using an Agilent BioAnalyzer. cDNA and analysed using a Leica SP1 confocal microscope.
Exosome isolation and analysis. Throughout these studies, complete media with exosome-depleted FCS (following 100'000g centrifugation) was used (Thery et al., 2006) . Exosomes were purified by a combination of ultracentrifugation and using Exoquick solution (SBI System Bioscience) (Taylor et al., 2011) , as previously reported and tested (King et al., 2012) . Cell supernatant was centrifuged at 300g for 10 minutes. Cell-free supernatant was further centrifuged at 2,000g and then 10,000g to remove dead cells and cell debris. Exosomes were then purified from the resulting supernatant using Exoquick solution (Taylor et al., 2011) . Exosomes recovered by this method were functionally comparable to exosomes recovered by 100'000g ultracentrifugation method ( Figure S6 ). Exosomes were quantified using a CD63, CD9 and CD81 ELISA, with a standard curve of known CD63 + CD9 + or CD81 + exosomes, respectively (SBI System Bioscience). In some experiments, exosomes were stained with anti-CD63 (NVG-2) and anti-CD9
(MZ3) and analysed using a BD LSR II flow cytometer. The size distribution of purified exosomes was also confirmed using dynamic light scatter (DLS, Malvern instruments). For in vitro assays, a titration of purified exosomes from 10 4 to 5 x 10 7 was used with 10 4 T H cells ( Figure S6) . In all other experiments, unless indicated, 10 7 T cell-derived exosomes were used.
All FACS analysis was performed using a BD LSRII and TreeStar FlowJo and all cell sorting was performed using a BD Aria II with CellQuest software.
